F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Ribavirin

Page 1 of 2 ( 52 items )
<<
1
2
>>

1	Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment 2/24/2023 1:35:50 PM \| Browse: 504 \| Download: 1043
2	Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C 12/2/2022 12:50:19 PM \| Browse: 524 \| Download: 1706
3	Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages 6/24/2021 7:26:32 AM \| Browse: 609 \| Download: 1753
4	Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over 9/21/2020 4:02:08 PM \| Browse: 835 \| Download: 2299
5	Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature 5/6/2019 10:43:10 AM \| Browse: 1183 \| Download: 2398
6	Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus 4/4/2018 1:15:45 PM \| Browse: 1383 \| Download: 2612
7	Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 12/5/2017 1:55:00 AM \| Browse: 1267 \| Download: 2473
8	Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review 5/17/2017 6:29:40 AM \| Browse: 1594 \| Download: 2747
9	Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection 2/6/2017 9:08:00 AM \| Browse: 1189 \| Download: 2735
10	Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin 1/22/2017 8:28:00 AM \| Browse: 1510 \| Download: 2833
11	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 1276 \| Download: 2782
12	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1824 \| Download: 2999
13	Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 10/12/2016 2:18:00 PM \| Browse: 1409 \| Download: 1929
14	Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience 8/3/2016 8:11:00 AM \| Browse: 1761 \| Download: 3038
15	Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus 3/2/2016 1:35:00 PM \| Browse: 1955 \| Download: 3607
16	Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma 2/25/2016 7:04:00 PM \| Browse: 1331 \| Download: 2567
17	Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia 2/22/2016 3:38:00 PM \| Browse: 1453 \| Download: 3041
18	Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy 1/23/2016 5:08:00 PM \| Browse: 1613 \| Download: 2267
19	Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C 1/20/2016 5:04:00 PM \| Browse: 1240 \| Download: 2258
20	Ribavirin: Past, present and future 1/15/2016 9:49:00 AM \| Browse: 1536 \| Download: 2112
21	Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management 1/15/2016 9:49:00 AM \| Browse: 1389 \| Download: 1877
22	Hepatitis C genotype 4: The past, present, and future 12/4/2015 3:24:00 PM \| Browse: 2050 \| Download: 2840
23	Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients 12/2/2015 12:20:00 PM \| Browse: 1837 \| Download: 2192
24	Hepatitis C in hemodialysis patients 12/2/2015 12:01:00 PM \| Browse: 1352 \| Download: 1904
25	Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development 11/27/2015 5:17:00 PM \| Browse: 1573 \| Download: 2927
26	Hepatitis E virus infection: Epidemiology and treatment implications 11/12/2015 5:09:00 PM \| Browse: 1401 \| Download: 2538
27	Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance 11/9/2015 6:35:00 PM \| Browse: 1509 \| Download: 2066
28	Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 6/29/2015 4:40:00 PM \| Browse: 1486 \| Download: 2842
29	Hepatitis C: New challenges in liver transplantation 5/20/2015 5:01:00 PM \| Browse: 1279 \| Download: 2651
30	Natural interferon-beta treatment for patients with chronic hepatitis C in Japan 5/19/2015 5:28:00 PM \| Browse: 1423 \| Download: 2132
31	Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study 5/18/2015 5:02:00 PM \| Browse: 1527 \| Download: 1957
32	Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection 5/18/2015 5:02:00 PM \| Browse: 1195 \| Download: 2148
33	Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control 3/30/2015 5:46:00 PM \| Browse: 1500 \| Download: 2556
34	Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6 3/13/2015 3:29:00 PM \| Browse: 1447 \| Download: 2080
35	Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings 2/11/2015 5:56:00 PM \| Browse: 1609 \| Download: 2362
36	Retreatment with peginterferon and ribavirin in chronic hepatitis C 2/11/2015 5:56:00 PM \| Browse: 1325 \| Download: 1772
37	Study of pruritus in chronic hepatitis C patients 12/20/2014 9:24:00 PM \| Browse: 1343 \| Download: 2094
38	Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection 12/5/2014 11:43:00 AM \| Browse: 1422 \| Download: 1996
39	New treatments for chronic hepatitis C: an overview for paediatricians 12/5/2014 11:43:00 AM \| Browse: 1649 \| Download: 2398
40	Telaprevir/boceprevir era: From bench to bed and back 9/16/2014 8:07:00 PM \| Browse: 1650 \| Download: 1950
41	Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients 9/16/2014 4:56:00 PM \| Browse: 1315 \| Download: 1180
42	Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C 9/16/2014 3:23:00 PM \| Browse: 1271 \| Download: 1120
43	Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 9/15/2014 8:53:00 PM \| Browse: 1472 \| Download: 1566
44	Hepatitis C, stigma and cure 9/12/2014 8:41:00 PM \| Browse: 1595 \| Download: 1469
45	Hepatitis C genotype 6: A concise review and response-guided therapy proposal 9/10/2014 4:40:00 PM \| Browse: 1412 \| Download: 1509
46	Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy 9/5/2014 2:19:00 PM \| Browse: 1247 \| Download: 1488
47	Challenges in managing hepatitis C virus infection in cancer patients 9/1/2014 2:51:00 PM \| Browse: 1229 \| Download: 1148
48	Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection 9/1/2014 2:51:00 PM \| Browse: 1391 \| Download: 1638
49	Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children 8/28/2014 5:50:00 PM \| Browse: 1693 \| Download: 1594
50	Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C 8/26/2014 3:10:00 PM \| Browse: 1407 \| Download: 1916

Page 1 of 2 ( 52 items )
<<
1
2
>>

1	Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment 2/24/2023 1:35:50 PM \| Browse: 504 \| Download: 1043
2	Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C 12/2/2022 12:50:19 PM \| Browse: 524 \| Download: 1706
3	Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages 6/24/2021 7:26:32 AM \| Browse: 609 \| Download: 1753
4	Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over 9/21/2020 4:02:08 PM \| Browse: 835 \| Download: 2299
5	Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature 5/6/2019 10:43:10 AM \| Browse: 1183 \| Download: 2398
6	Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus 4/4/2018 1:15:45 PM \| Browse: 1383 \| Download: 2612
7	Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 12/5/2017 1:55:00 AM \| Browse: 1267 \| Download: 2473
8	Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review 5/17/2017 6:29:40 AM \| Browse: 1594 \| Download: 2747
9	Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection 2/6/2017 9:08:00 AM \| Browse: 1189 \| Download: 2735
10	Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin 1/22/2017 8:28:00 AM \| Browse: 1510 \| Download: 2833
11	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 1276 \| Download: 2782
12	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1824 \| Download: 2999
13	Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 10/12/2016 2:18:00 PM \| Browse: 1409 \| Download: 1929
14	Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience 8/3/2016 8:11:00 AM \| Browse: 1761 \| Download: 3038
15	Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus 3/2/2016 1:35:00 PM \| Browse: 1955 \| Download: 3607
16	Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma 2/25/2016 7:04:00 PM \| Browse: 1331 \| Download: 2567
17	Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia 2/22/2016 3:38:00 PM \| Browse: 1453 \| Download: 3041
18	Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy 1/23/2016 5:08:00 PM \| Browse: 1613 \| Download: 2267
19	Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C 1/20/2016 5:04:00 PM \| Browse: 1240 \| Download: 2258
20	Ribavirin: Past, present and future 1/15/2016 9:49:00 AM \| Browse: 1536 \| Download: 2112
21	Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management 1/15/2016 9:49:00 AM \| Browse: 1389 \| Download: 1877
22	Hepatitis C genotype 4: The past, present, and future 12/4/2015 3:24:00 PM \| Browse: 2050 \| Download: 2840
23	Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients 12/2/2015 12:20:00 PM \| Browse: 1837 \| Download: 2192
24	Hepatitis C in hemodialysis patients 12/2/2015 12:01:00 PM \| Browse: 1352 \| Download: 1904
25	Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development 11/27/2015 5:17:00 PM \| Browse: 1573 \| Download: 2927
26	Hepatitis E virus infection: Epidemiology and treatment implications 11/12/2015 5:09:00 PM \| Browse: 1401 \| Download: 2538
27	Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance 11/9/2015 6:35:00 PM \| Browse: 1509 \| Download: 2066
28	Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 6/29/2015 4:40:00 PM \| Browse: 1486 \| Download: 2842
29	Hepatitis C: New challenges in liver transplantation 5/20/2015 5:01:00 PM \| Browse: 1279 \| Download: 2651
30	Natural interferon-beta treatment for patients with chronic hepatitis C in Japan 5/19/2015 5:28:00 PM \| Browse: 1423 \| Download: 2132
31	Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study 5/18/2015 5:02:00 PM \| Browse: 1527 \| Download: 1957
32	Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection 5/18/2015 5:02:00 PM \| Browse: 1195 \| Download: 2148
33	Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control 3/30/2015 5:46:00 PM \| Browse: 1500 \| Download: 2556
34	Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6 3/13/2015 3:29:00 PM \| Browse: 1447 \| Download: 2080
35	Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings 2/11/2015 5:56:00 PM \| Browse: 1609 \| Download: 2362
36	Retreatment with peginterferon and ribavirin in chronic hepatitis C 2/11/2015 5:56:00 PM \| Browse: 1325 \| Download: 1772
37	Study of pruritus in chronic hepatitis C patients 12/20/2014 9:24:00 PM \| Browse: 1343 \| Download: 2094
38	Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection 12/5/2014 11:43:00 AM \| Browse: 1422 \| Download: 1996
39	New treatments for chronic hepatitis C: an overview for paediatricians 12/5/2014 11:43:00 AM \| Browse: 1649 \| Download: 2398
40	Telaprevir/boceprevir era: From bench to bed and back 9/16/2014 8:07:00 PM \| Browse: 1650 \| Download: 1950
41	Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients 9/16/2014 4:56:00 PM \| Browse: 1315 \| Download: 1180
42	Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C 9/16/2014 3:23:00 PM \| Browse: 1271 \| Download: 1120
43	Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 9/15/2014 8:53:00 PM \| Browse: 1472 \| Download: 1566
44	Hepatitis C, stigma and cure 9/12/2014 8:41:00 PM \| Browse: 1595 \| Download: 1469
45	Hepatitis C genotype 6: A concise review and response-guided therapy proposal 9/10/2014 4:40:00 PM \| Browse: 1412 \| Download: 1509
46	Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy 9/5/2014 2:19:00 PM \| Browse: 1247 \| Download: 1488
47	Challenges in managing hepatitis C virus infection in cancer patients 9/1/2014 2:51:00 PM \| Browse: 1229 \| Download: 1148
48	Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection 9/1/2014 2:51:00 PM \| Browse: 1391 \| Download: 1638
49	Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children 8/28/2014 5:50:00 PM \| Browse: 1693 \| Download: 1594
50	Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C 8/26/2014 3:10:00 PM \| Browse: 1407 \| Download: 1916